Raymond James analyst Bobby Zolper assumes coverage on Itron (NASDAQ: ITRI) with a Underperform rating.The analyst comments "We resume coverage ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot New Coverage New Coverage